Overexpression of human lecithin:cholesterol acyltransferase in mice offers no protection against diet-induced atherosclerosis

APMIS

Volumn 108, Issue 5, 2000, Pages 336-342

  Mehlum, Anja ^a   Gjernes, Elisabeth ^a   Solberg, Lars Aage ^b   Hagve, Tor Arne ^c   Prydz, Hans ^a  

^a UNIVERSITY OF OSLO   (Norway)

^b Department of Neurology   (Norway)

^c OSLO UNIVERSITY HOSPITAL   (Norway)

Author keywords

Atherosclerosis; LCAT; Lipid; Lipoprotein; Transgenic mice

Indexed keywords

HIGH DENSITY LIPOPROTEIN CHOLESTEROL; PHOSPHATIDYLCHOLINE STEROL ACYLTRANSFERASE; TRIACYLGLYCEROL;

ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; ATHEROGENIC DIET; ATHEROSCLEROSIS; CHOLESTEROL BLOOD LEVEL; FEMALE; GENE OVEREXPRESSION; LIPOPROTEIN BLOOD LEVEL; MALE; NONHUMAN; PRIORITY JOURNAL; RAT; TRANSGENIC MOUSE; TRIACYLGLYCEROL BLOOD LEVEL;

EID: 0033920220     PISSN: 09034641     EISSN: None     Source Type: Journal    
DOI: 10.1034/j.1600-0463.2000.d01-65.x     Document Type: Article

References (26)

1. 1. Jonas A. Lecithin-cholesterol acyltransferase in the metabolism of high-density lipoproteins. Biochim Biophys Acta 1991;1084:205-20.
2. 2. Glomset JA, Assmann G, Gjone E, Norum KR. Lecithin:cholesterol acyltransferase deficiency and fish eye disease. In: Scriver CR, Beaudet AL, Sly WS, Valle D, editors. The metabolic and molecular bases of inherited disease. 7th ed. USA: McGraw-Hill, Inc. 1995:1933-51.
3. 3. Glomset JA. The plasma lecithin:cholesterol acyltransferase reaction. J Lipid Res 1968;9:155-67.
4. 4. Fielding CJ, Fielding PE. Molecular physiology of reverse cholesterol transport. J Lipid Res 1995;36:211-28.
5. 5. Mehlum A, Staels B, Duverger N, Tailleux A, Castro G, Fievet C, et al. Tissue-specific expression of the human gene for lecithin:cholesterol acyltransferase in transgenic mice alters blood lipids, lipoproteins and lipases towards a less atherogenic profile. Eur J Biochem 1995;230:567-75.
6. 6. Berenson GS, Wattigney WA, Bao W, Srinivasan SR, Radhakrishnamurthy B. Rationale to study the early natural history of heart disease: the Bogalusa Heart Study. Am J Med Sci 1995;310:S22-8.
7. 7. Mehlum A, Muri M, Hagve TA, Solberg LÅ, Prydz H. Mice overexpressing human lecithin:-cholesterol acyltransferase are not protected against diet-induced atherosclerosis. APMIS. 1997;105:861-8.
8. 8. Vaisman B, Klein H, Rouis M, Bérard AM, Kindt MR, Talley GD, et al. Overexpression of human lecithin:cholesterol acyltransferase leads to hyperalphalipoproteinemia in transgenic mice. J Biol Chem 1995;270:12269-75.
9. 9. Francone OL, Gong EL, Ng DS, Fielding CJ, Rubin EM. Expression of human lecithin-cholesterol acyltransferase in transgenic mice. J Clin Invest 1995;96:1440-8.
10. 10. Bérard AM, Föger B, Remaley A, Shamburek R, Vaisman BL, Talley G, et al. High plasma HDL concentration associated with enhanced atherosclerosis in transgenic mice overexpressing lecithin-cholesteryl acyltransferase. Nat Med 1997;3: 744-9.
11. 11. Hoeg JM, Vaisman BL, Demosky SJ Jr, Meyn SM, Talley GD, Hoyt RF Jr, et al. Lecithin:cholesterol acyltransferase overexpression generates hyperalpha-lipoproteinemia and a nonatherogenic lipoprotein pattern in transgenic rabbits. J Biol Chem 1996;271:4396-402.
12. 12. Brousseau ME, Santamarina-Fojo S, Zech LA, Bérard AM, Vaisman BL, Meyn SM, et al. Hyperalphalipoproteinemia in human lecithin cholesterol acyltransferase transgenic rabbits. In vivo apolipoprotein A-I catabolism is delayed in a gene dose-dependent manner. J Clin Invest 1996;97:1844-51.
13. 13. Hoeg JM, Santamarina-Fojo S, Bérard AM, Cornhill JF, Herderick EE, Feldman SH, et al. Overexpression of lecithin:cholesterol acyltransferase in transgenic rabbits prevents diet-induced atherosclerosis. Proc Natl Acad Sci USA 1996;93:11448-53.
14. 14. Brousseau ME, Hoeg JM. Transgenic rabbits as models for atherosclerosis research. J Lipid Res 1999;40:365-75.
15. 15. Dugi KA, Vaisman BL, Sakai N, Knapper CL, Meyn SM, Brewer HB Jr, et al. Adenovirus-mediated expression of hepatic lipase in LCAT transgenic mice. J Lipid Res 1997;38:1822-32.
16. 16. Chen CH, Albers JJ. Characterization of proteoliposomes containing apoprotein A-I: a new substrate for the measurement of lecithin:cholesterol acyltransferase activity. J Lipid Res 1982;23:680-91.
17. 17. Berard A, Shamburek RD, Vaisman B, Meyn S, Kindt M, Albers J, et al. Differential dietary response of mice overexpressing hLCAT Circulation 1994;90:1-82 (Abstract).
18. 18. Levine JB, Zak B. Automated determination of serum total cholesterol. Clin Chim Acta 1964;10: 381-4.
19. 19. Bachorik PS, Albers JJ. Precipitation methods for quantification of lipoproteins. Methods Enzymol 1986;129:78-85.
20. 20. Fossati P, Prencipe L. Serum triglycerides determined colorimetrically with one enzyme that produces hydrogen peroxide. Clin Chem 1982; 28:2077-80.
21. 21. Nishina PM, Verstuyft J, Paigen B. Synthetic low and high fat diets for the study of atherosclerosis in the mouse. J Lipid Res 1990;31:859-69.
22. 22. Dueland S, France D, Wang SL, Trawik JD, Davis RA. Cholesterol 7alpha-hydroxylase influences the expression of hepatic apoA-I in two inbred mouse strains displaying different susceptibilities to atherosclerosis and in hepatoma cells. J Lipid Res 1997;38:1445-53.
23. 23. Föger B, Vaisman BL, Paigen B, Hoyt RF Jr, Brewer B Jr, Santamarina-Fojo S. CETP modulates the development of aortic atherosclerosis in LCAT-transgenic mice. Circulation Suppl 1997; 1:110.
24. 24. Collet X, Tall AR, Serajuddin H, Guendouzi K, Royer L, Oliveira H, et al. Remodeling of HDL by CETP in vivo and by CETP and hepatic lipase in vitro results in enhanced uptake of HDL CE by cells expressing scavenger receptor B-I. J Lipid Res 1999;40:1185-93.
25. 25. Brousseau ME, Santamarina-Fojo S, Vaisman BL, Applebaum-Bowden D, Berard AM, Talley G, et al. Overexpression of human lecithin:cholesterol acyltransferase in cholesterol-fed rabbits: LDL metabolism and HDL metabolism are affected in a gene dose-dependent manner. J Lipid Res 1999;38:2537-47.
26. 26. Paigen B, Holmes PA, Mitchell D, Albee D. Comparison of atherosclerotic lesions and HDL-lipid levels in male, female, and testosterone-treated female mice from strains C57B1/6, Ba1b/c and C3H. Atherosclerosis 1987;64:215-21.